Neighbourly Pharmacy (TSE:NBLY) Price Target Lowered to C$28.00 at National Bankshares

Neighbourly Pharmacy (TSE:NBLYGet Rating) had its price target reduced by equities research analysts at National Bankshares from C$35.00 to C$28.00 in a note issued to investors on Wednesday, BayStreet.CA reports. The firm presently has a “sector perform” rating on the stock. National Bankshares’ price target would suggest a potential upside of 14.24% from the company’s previous close.

Several other research analysts also recently commented on the stock. TD Securities started coverage on shares of Neighbourly Pharmacy in a report on Monday, April 11th. They issued a “buy” rating and a C$39.00 price target for the company. Royal Bank of Canada lifted their price objective on shares of Neighbourly Pharmacy from C$39.00 to C$42.00 and gave the stock an “outperform” rating in a report on Monday, March 21st. Industrial Alliance Securities raised shares of Neighbourly Pharmacy to a “buy” rating and set a C$40.00 price objective for the company in a report on Monday, March 21st. Finally, Desjardins lifted their price objective on shares of Neighbourly Pharmacy from C$33.00 to C$35.00 in a report on Thursday, March 24th.

TSE:NBLY traded down C$0.46 during trading hours on Wednesday, hitting C$24.51. The stock had a trading volume of 21,006 shares, compared to its average volume of 52,543. The business’s 50 day moving average price is C$26.40. The company has a debt-to-equity ratio of 40.22, a current ratio of 1.78 and a quick ratio of 0.91. Neighbourly Pharmacy has a one year low of C$23.25 and a one year high of C$40.07. The stock has a market cap of C$843.90 million and a price-to-earnings ratio of -9.55.

About Neighbourly Pharmacy (Get Rating)

Neighbourly Pharmacy Inc owns and operates a chain of retail pharmacies in Canada. It operates in 172 locations. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for Neighbourly Pharmacy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neighbourly Pharmacy and related companies with's FREE daily email newsletter.